全文获取类型
收费全文 | 6498篇 |
免费 | 590篇 |
国内免费 | 54篇 |
专业分类
耳鼻咽喉 | 48篇 |
儿科学 | 120篇 |
妇产科学 | 304篇 |
基础医学 | 757篇 |
口腔科学 | 153篇 |
临床医学 | 733篇 |
内科学 | 1438篇 |
皮肤病学 | 90篇 |
神经病学 | 610篇 |
特种医学 | 455篇 |
外科学 | 707篇 |
综合类 | 140篇 |
一般理论 | 2篇 |
预防医学 | 378篇 |
眼科学 | 170篇 |
药学 | 364篇 |
中国医学 | 62篇 |
肿瘤学 | 611篇 |
出版年
2023年 | 32篇 |
2022年 | 53篇 |
2021年 | 144篇 |
2020年 | 84篇 |
2019年 | 183篇 |
2018年 | 212篇 |
2017年 | 169篇 |
2016年 | 190篇 |
2015年 | 245篇 |
2014年 | 273篇 |
2013年 | 352篇 |
2012年 | 442篇 |
2011年 | 473篇 |
2010年 | 308篇 |
2009年 | 304篇 |
2008年 | 334篇 |
2007年 | 323篇 |
2006年 | 366篇 |
2005年 | 270篇 |
2004年 | 265篇 |
2003年 | 239篇 |
2002年 | 209篇 |
2001年 | 162篇 |
2000年 | 145篇 |
1999年 | 125篇 |
1998年 | 95篇 |
1997年 | 90篇 |
1996年 | 60篇 |
1995年 | 44篇 |
1994年 | 38篇 |
1993年 | 39篇 |
1992年 | 75篇 |
1991年 | 78篇 |
1990年 | 66篇 |
1989年 | 73篇 |
1988年 | 51篇 |
1987年 | 51篇 |
1986年 | 59篇 |
1985年 | 45篇 |
1984年 | 39篇 |
1983年 | 41篇 |
1982年 | 30篇 |
1981年 | 28篇 |
1980年 | 19篇 |
1979年 | 23篇 |
1978年 | 19篇 |
1977年 | 19篇 |
1975年 | 20篇 |
1974年 | 30篇 |
1973年 | 21篇 |
排序方式: 共有7142条查询结果,搜索用时 15 毫秒
1.
Her-Shyong Shiah Nai-Jung Chiang Chia-Chi Lin Chia-Jui Yen Hui-Jen Tsai Shang-Yin Wu Wu-Chou Su Kwang-Yu Chang Ching-Chiung Wang Jang-Yang Chang Li-Tzong Chen 《The oncologist》2021,26(4):e567-e579
Lessons Learned
- SCB01A is a novel microtubule inhibitor with vascular disrupting activity.
- This first‐in‐human study demonstrated SCB01A safety, pharmacokinetics, and preliminary antitumor activity.
- SCB01A is safe and well tolerated in patients with advanced solid malignancies with manageable neurotoxicity.
2.
3.
4.
Nonsurgical management of partial adhesive small-bowel obstruction with oral therapy: a randomized controlled trial 总被引:2,自引:0,他引:2
下载免费PDF全文
![点击此处可从《Canadian Medical Association journal》网站下载免费的PDF全文](/ch/ext_images/free.gif)
5.
Feng-Yuan Liu Chien-Yu Lin Joseph T Chang Shu-Hang Ng Shy-Chyi Chin Hung-Ming Wang Chun-Ta Liao Sheng-Chieh Chan Tzu-Chen Yen 《Journal of nuclear medicine》2007,48(10):1614-1619
Conventional work-up (CWU) with chest radiography, abdominal ultrasonography, and skeletal scintigraphy has limited value in M staging of nonkeratinizing nasopharyngeal carcinoma (NPC). Our aim was to evaluate whether (18)F-FDG PET could replace CWU by comparing their diagnostic efficacies. METHODS: Patients with histologically proven nonkeratinizing NPC and no prior treatment were prospectively enrolled. All study participants underwent CWU and (18)F-FDG PET for primary M staging. Distant metastasis was considered to be present if there was any reliable evidence identified within 1 y after diagnosis. The comparative diagnostic efficacies of (18)F-FDG PET, CWU, and the combination of (18)F-FDG PET and CWU (PET+CWU) were evaluated using the areas under the receiver-operating-characteristic (ROC) curves. RESULTS: Sixty-one (20.3%) of 300 eligible patients were found to have distant metastases. On a patient-based analysis, (18)F-FDG PET was found to be more effective than CWU (P < 0.001), whereas it was equally effective with PET+CWU (P = 0.130). On region-based analyses, (18)F-FDG PET was more effective than skeletal scintigraphy and chest radiography for detecting bone metastases (P < 0.001) and chest metastases (P < 0.001), respectively. (18)F-FDG PET and abdominal ultrasound were equally effective for detecting hepatic metastases (P = 0.127). On region-based analyses, the combination of (18)F-FDG PET and CWU did not yield any noticeable increase in diagnostic efficacy. CONCLUSION: (18)F-FDG PET can replace CWU in primary M staging of nonkeratinizing NPC. 相似文献
6.
7.
8.
BACKGROUND: There are obvious advantages to increasing donor retention. However, for reasons of blood safety, certain donors may, in fact, be more desirable to retain than others. “Safe” donors are defined as those who provided a blood donation that was negative on all laboratory screening tests and who subsequently reported no behavioral risks in response to an anonymous survey. This study identifies the most important factors affecting the intention of “safe” donors to provide another donation. STUDY DESIGN AND METHODS: An anonymous survey asking about donation history, sexual history, injecting drug use, and recent donation experience was mailed to 50,162 randomly selected allogeneic donors (including directed donors) who gave blood from April through July or from October through December 1993 at one of the five United States blood centers participating in the Retrovirus Epidemiology Donor Study. Before mailing, questionnaires were coded to designate donors with nonreactive laboratory screening tests at their most recent donation. RESULTS: A total of 34,726 donors (69%) responded, with substantially higher response among repeat donors. According to reported intentions only, the vast majority of “safe” donors indicated a high likelihood of donating again within the next 12 months. Only 3.4 percent reported a low likelihood of donating again. A comparison of those likely to return and those unlikely to return reveals significant differences in demographics and in ratings of the donation experience. A higher proportion of those unlikely to return were first-time donors, minority-group donors, and donors with less education. The highest projected loss among “safe” donors was seen for those who gave a fair to poor assessment of their treatment by blood center staff or of their physical well-being during or after donating. CONCLUSION: These data suggest that efforts to improve donors' perceptions of their donation experience, as well as attention to the physical effects of blood donation, may aid in the retention of both repeat and first-time donors. 相似文献
9.
10.